Psychological Distress as a Negative Survival Factor for Patients with Hematologic Malignancies Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation

被引:12
|
作者
Park, Ji Eun [1 ]
Kim, Kyung Im [1 ]
Yoon, Sung Soo [2 ]
Hahm, Bong Jin [3 ]
Lee, Sang Min [1 ]
Yoon, Jeong Hyun [5 ]
Shin, Wan Gyoon [1 ]
Lee, Hye Suk [4 ]
Oh, Jung Mi [1 ]
机构
[1] Seoul Natl Univ, Dept Clin Pharm, Coll Pharm, Seoul 151742, South Korea
[2] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea
[3] Seoul Natl Univ Hosp, Dept Neuropsychiat, Seoul 110744, South Korea
[4] Seoul Natl Univ Hosp, Dept Pharm, Seoul 110744, South Korea
[5] Pusan Natl Univ, Dept Clin Pharm, Coll Pharm, Pusan 609735, South Korea
来源
PHARMACOTHERAPY | 2010年 / 30卷 / 12期
关键词
psychological stress; distress; hematopoietic stem cell transplantation; hematologic malignancy; survival; BONE-MARROW-TRANSPLANTATION; UMBILICAL-CORD BLOOD; ACUTE MYELOID-LEUKEMIA; SYMPTOM DISTRESS; RISK-FACTOR; DEPRESSION; MORTALITY; IMPACT; ADULTS; ASSOCIATION;
D O I
10.1592/phco.30.12.1239
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Study Objective To evaluate the influence of distress on overall survival of patients with hematologic malignancies who underwent allogeneic stem cell transplantation (allo-SCT) and to analyze the possible risk factors for death Design Retrospective cohort study Setting Large tertiary care teaching hospital Patients Seventy-seven patients (aged >= 15 yrs) with hematologic malignancies who underwent allo-SCT between January 2000 and August 2007, 20 patients with distress history were matched in a 1 3 ratio with 57 patients without distress history Measurements and Main Results The primary outcome was overall survival, defined as the time from allo-SCT to disease-related death or last date of follow-up Secondary outcomes were time to hematologic recovery (absolute neutrophil count >= 500 cells/mm(3)) from day of allo-SCT, length of hospital stay, and opioid usage Sociodemographic information and clinical characteristics were analyzed for possible risk factors Patient history of psychological distress resulted in a significantly higher mortality rate in the first year after allo-SCT (hazard ratio [HR] 3 05, 95% confidence interval [CI] 1 48-6 28, p=0 001) and led to a shorter overall survival rate (HR 1 63, 95% CI 0 86-3 10 p=0 133) However, psychological distress had no effect on hospital length of stay, hematologic recovery time, opioid usage status, or dose of opioid analgesics used Factors associated with death after allo-SCT in the univariate analysis (p<0 05) were high-relapse risk disease, umbilical cord blood SCT, total-body irradiation-containing conditioning regimen, and higher educational background In the multivariate analysis, high relapse risk (HR 3 85, 95% CI 1 81-8 20, p<0 001) and total-body irradiation-containing conditioning regimen (HR 3 50, 95% CI 1 29-9 51, p=0 01) were identified as risk factors for death Conclusion A history of psychological distress before allo-SCT, after adjusting for other patient- and disease-related prognostic factors, had a significant influence on early death in the first year after transplantation
引用
收藏
页码:1239 / 1246
页数:8
相关论文
共 50 条
  • [11] Increased Hepatic Iron Content Predicts Poor Survival in Patients With Iron Overload Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation
    Sivgin, Serdar
    Baldane, Suleyman
    Deniz, Kemal
    Zararsiz, Gokmen
    Kaynar, Leylagul
    Cetin, Mustafa
    Unal, Ali
    Eser, Bulent
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 : S10 - S18
  • [12] Pulmonary Dysfunction in Survivors of Childhood Hematologic Malignancies After Allogeneic Hematopoietic Stem Cell Transplantation
    Inaba, Hiroto
    Yang, Jie
    Pan, Jianmin
    Stokes, Dennis C.
    Krasin, Matthew J.
    Srinivasan, Ashok
    Hartford, Christine M.
    Pui, Ching-Hon
    Leung, Wing
    CANCER, 2010, 116 (08) : 2020 - 2030
  • [13] Cytomegalovirus Infection in Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation in Portugal: A Five-Year Retrospective Review
    Sousa, Hugo
    Boutolleau, David
    Ribeiro, Joana
    Teixeira, Ana L.
    Vaz, Carlos Pinho
    Campilho, Fernando
    Branca, Rosa
    Campos, Antonio, Jr.
    Baldaque, Ines
    Medeiros, Rui
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (12) : 1958 - 1967
  • [14] Allogeneic hematopoietic stem cell transplantation following donor CIK cell infusion: A phase I study in patients with relapsed/refractory hematologic malignancies
    Luo, Yun
    Zeng, Han-Qing
    Shen, Yan
    Zhang, Ping
    Lou, Shi-Feng
    Chen, Lin
    Deng, Jian-Chuan
    LEUKEMIA RESEARCH, 2016, 48 : 6 - 10
  • [15] Positive psychological experiences in allogeneic hematopoietic stem cell transplantation
    Amonoo, Hermioni L.
    Brown, Lydia A.
    Scheu, Carlyn F.
    Millstein, Rachel A.
    Pirl, William F.
    Vitagliano, Halyna L.
    Antin, Joseph H.
    Huffman, Jeff C.
    PSYCHO-ONCOLOGY, 2019, 28 (08) : 1633 - 1639
  • [16] Favorable Outcomes in Patients Surviving 5 or More Years after Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
    Le, Robert Quan
    Bevans, Margaret
    Savani, Bipin N.
    Mitchell, Sandra A.
    Stringaris, Kate
    Koklanaris, Eleftheria
    Barrett, A. John
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (08) : 1162 - 1170
  • [17] The Impact of Pretransplant Hypoalbuminemia on Survival in patients With Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Nutritional Problem?
    Sivgin, S.
    Baldane, S.
    Ozenmis, T.
    Keklik, M.
    Kaynar, L.
    Kurnaz, F.
    Sivgin, H.
    Zararsa, G.
    Cetin, M.
    Unal, A.
    Eser, B.
    TRANSPLANTATION PROCEEDINGS, 2013, 45 (09) : 3371 - 3374
  • [18] The use of second allogeneic hematopoietic stem cell transplantation for hematologic malignancies relapsed after the first: Does it worth to do?
    Goksoy, Hasan Sami
    Arat, Mutlu
    TRANSFUSION AND APHERESIS SCIENCE, 2016, 54 (01) : 91 - 98
  • [19] MOBILIZED HEMATOPOIETIC STEM CELLS AS A PREFERED SOURCE IN AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH HEMATOLOGIC MALIGNANCIES
    Rastvorceva, R. Grubovic
    Useini, S.
    Petkovikj, E.
    Pivkova, A.
    Panovska-Stavridis, I.
    Stojanoski, Z.
    CYTOTHERAPY, 2023, 25 (06) : S128 - S129
  • [20] Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies
    Lin, Richard J.
    Elko, Theresa A.
    Devlin, Sean M.
    Shahrokni, Armin
    Jakubowski, Ann A.
    Dahi, Parastoo B.
    Perales, Miguel-Angel
    Tamari, Roni
    Shaffer, Brian C.
    Sauter, Craig S.
    Papadopoulos, Esperanza B.
    Gyurkocza, Boglarka
    Korc-Grodzicki, Beatriz
    Barker, Juliet N.
    Maloy, Molly A.
    Giralt, Sergio A.
    BONE MARROW TRANSPLANTATION, 2020, 55 (01) : 157 - 164